The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A study of denileukin diftitox to treat refractory ovarian cancer.
Cheryl M. Czerlanis
Research Funding - Eisai
Maureen Drakes
Research Funding - Eisai
Amira Elmishad
Research Funding - Eisai; Eisai
Kelly Kosik
Research Funding - Eisai
Mala Parthasarathy
Research Funding - Eisai
Ronald Potkul
Research Funding - Eisai
Donna M. Smith
Research Funding - Eisai
Zheng Yu
Research Funding - Eisai
Sandra Zakrzewski
Research Funding - Eisai
Patrick J. Stiff
Research Funding - Eisai